Precision BioSciences
DTIL
100 hedge funds and large institutions have $60M invested in Precision BioSciences in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 35 reducing their positions, and 18 closing their positions.
86% more call options, than puts
Call options by funds: $26K | Put options by funds: $14K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.04% less ownership
Funds ownership: 1.56% → 1.52% (-0.04%)
6% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 18
2% less funds holding
Funds holding: 102 → 100 (-2)
13% less capital invested
Capital invested by funds: $68.6M → $60M (-$8.63M)
40% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.44M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$630K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$520K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$393K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$326K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$1.8M |
| 2 |
Millennium Management
New York
|
-$1.12M |
| 3 |
BlackRock
New York
|
-$874K |
| 4 |
Renaissance Technologies
New York
|
-$780K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$640K |
DTIL Hedge Fund Activity: Q4 2022 in Review
100 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2022, worth a combined $60M — down 13% from $68.6M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of DTIL and 17 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 21 added.
The largest buyer was Great Point Partners, adding an estimated $1.44M. The largest seller was Marshall Wace, cutting an estimated $1.8M.
- 100 institutional investors held Precision BioSciences (DTIL) as of Q4 2022, down from 102 in Q3 2022.
- Funds reported $60M of Precision BioSciences stock for Q4 2022, down 13% quarter-over-quarter.
- 17 funds opened new Precision BioSciences positions in Q4 2022 and 18 closed out, a net change of -1 holder.
- The largest Precision BioSciences buyer in Q4 2022 was Great Point Partners, an estimated $1.44M added.
- The largest Precision BioSciences seller in Q4 2022 was Marshall Wace, an estimated $1.8M sold.
Based on aggregated 13F filings for Q4 2022.